Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sanofi India Limited ( (IN:SANOFI) ) has provided an update.
Sanofi India Limited announced the approval of its unaudited financial statements for the quarter and half-year ended June 30, 2025, reflecting compliance with SEBI regulations. The company also disclosed significant management changes, with the retirement of Ms. Renee Amonkar as Whole-time Director and Site Director – Goa, effective August 11, 2025, and the appointment of Mr. Mahadev Gawade as her successor. These changes are expected to impact the company’s leadership dynamics and strategic direction.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of healthcare products. The company is known for its innovative solutions in the pharmaceutical sector, catering to various therapeutic areas and contributing significantly to healthcare advancements.
Average Trading Volume: 526
Technical Sentiment Signal: Buy
Current Market Cap: 134B INR
See more data about SANOFI stock on TipRanks’ Stock Analysis page.